List view / Grid view
Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that Antonella Mancuso has been promoted to President, Global Commercial Operations and Chief Manufacturing Officer, responsible for Patheon's global commercial manufacturing operations . Ms. Mancuso will assume responsibility for all of…
25 January 2012 | By Merck
The FDA has approved an updated label for VYTORIN® (ezetimibe/simvastatin)...
25 January 2012 | By Roche
Roche announced that it is proposing to acquire all outstanding shares of Illumina, Inc...
24 January 2012 | By Sanofi
The FDA has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta)...
24 January 2012 | By Eli Lilly and Company
Elanco, announced that Lilly has signed an agreement to acquire ChemGen Corp., a privately held bioscience company...
24 January 2012 | By Novo Nordisk
Novo Nordisk announced that the company will establish a type 1 diabetes R&D center in Seattle, US...
24 January 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced that its Board of Directors has elected Gerald L. Storch to the Board...
23 January 2012 | By Roche
Establishment of a program to improve basic cancer care in Ethiopia...
20 January 2012 | By Novartis
If approved, Signifor would be the first approved medication targeting Cushing's disease...
20 January 2012 | By Biogen Idec and Elan Corporation, plc
The U.S. FDA has approved a product label change for TYSABRI...
20 January 2012 | By Novartis
Update of the Glivec® (imatinib)* label...
19 January 2012 | By Merck
Merck announced that it has entered into an agreement to resolve all claims related to Vioxx® in Canada...
19 January 2012 | By Bristol-Myers Squibb Company
Donation of $6.9 million in 2011 to support the HealthWell Foundation...
19 January 2012 | By B&W Tek
B&W Tek, Inc., is proud to introduce BWSpec™ 4.00...
19 January 2012 | By Acquire Media
Patheon and PROCAPS S.A. are pleased to announce an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing services...
